Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Dec. 3, 2010

View Archived Issues

Abiomed hopes to tap into STEMI market with study

Report from Europe: St. Jude receives CE mark, TGA approval for Penta lead

Washington roundup: CMS proposes trial coverage of MRI with ICDs, pacemakers

Deals roundup: Hanger Ortho completes ACP buy for nearly $155M

MDD's food for med-tech thought

Med-Tech Notes

Financings roundup: Sequenom seeks $84M via offering of 14M shares

RSNA notebook: Panel addresses safety in medical imaging use

People in the News

Product Briefs

Medtronic Spine's Horizon cleared for AIS treatment

MDD's Diagnostics Extra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...